Thanks to a partnership with the Orlando Museum of Art, Encore at Avalon Park welcomes the Art’s the Spark program. Providing the elderly who face memory, or other neurological issues with the opportunity to enjoy a wonderful experience in which they and their healthy caregivers can partake in a safe environment focused on art and its appreciation. Involvement The program allows the elderly to thrive creatively despite any cognitive impairments they may be experiencing. Art’s the Spark provides them with a creative outlet in which they can both look at, and create their own art. Some of the activities for those participating include: Interactive discussion with professional educators Private Gallery…

Summer is approaching fast and with it comes the dreaded heat. While some may embrace the accompanying warmth, it does not mean that there are not significant risks to prolonged exposure and the risks are hightened for the elderly. Seniors should not be limited in their activities due to their age. It is important for seniors to know the safest way to approach outdoor activities to minimize any risks. The following are some helpful ways seniors can be safe while enjoying the outdoors this summer. Hydrate Constantly – Dehydration is one of the biggest concerns for both the elderly and young alike. When you get older, it becomes more difficult…

Alzheimer’s is a debilitating disease that affects those we love most. As we age, we become more susceptible to this neurodegenerative disease which only gets worse as time passes. Over 50% of dementia cases are caused by Alzheimer’s disease resulting in memory loss issues, disorientation, and difficulty with language. Unfortunately, the causes of Alzheimer’s disease are not completely understood which is what makes it so difficult to treat. That is not to say that all hope is lost, however, as research continues to make great strides in finding better treatments. Congressional Backing The Global Alzheimer’s Platform Foundation, a nonprofit organization which focuses on expediting Alzheimer’s clinical trials, received a substantial…